Key stats
Fund info
Home page
Inception date
Oct 23, 2017
Structure
Canadian Mutual Fund Trust (ON)
Replication method
Synthetic
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Primary advisor
Evolve Funds Group, Inc.
ISIN
CA30051T2002
CUSIP
30051T200
FIGI
BBG00HYCFXH1
Identifiers
ISIN CA30051T2002
The fund is a passively managed ETF that provides exposure to 20 of the largest healthcare stocks in developed countries. The fund holds companies identified as Health Technology using FactSets Revere Business Industry Classification System. At any time, the fund manager can write covered call options at its discretion on not more than 33% of its securities, depending on market volatility and other factors. The index is and reviewed quarterly, assigning equal weights for each eligible security.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks101.53%
Health Technology99.55%
Bonds, Cash & Other−1.53%
Cash0.46%
Rights & Warrants−1.99%
Breakdown by region
North America71.94%
Europe28.06%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently asked questions
LIFE.B top holdings are Thermo Fisher Scientific Inc. and Abbott Laboratories, occupying 5.74% and 5.66% of the portfolio correspondingly.
LIFE.B last dividends amounted to 0.23 CAD. The month before, the issuer paid 0.23 CAD in dividends,
LIFE.B assets under management is 40.85 M CAD. It's risen 5.93% over the last month.
LIFE.B fund flows account for 6.93 M CAD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, LIFE.B pays dividends to its holders with the dividend yield of 11.67%. The last dividend (Aug 10, 2026) amounted to 0.23 CAD. The dividends are paid monthly.
LIFE.B shares are issued by Evolve Funds Group, Inc. under the brand Evolve. The ETF was launched on Oct 23, 2017, and its management style is Passive.
LIFE.B expense ratio is 0.65% meaning you'd have to pay 0.65% of your investment to help manage the fund.
LIFE.B follows the Solactive Global Healthcare 20 Index - CAD. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
LIFE.B invests in stocks.
LIFE.B price has risen by 5.67% over the last month, and its yearly performance shows a 0.13% increase. See more dynamics on LIFE.B price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 4.56% over the last month, showed a 11.42% increase in three-month performance and has increased by 12.30% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 4.56% over the last month, showed a 11.42% increase in three-month performance and has increased by 12.30% in a year.
LIFE.B trades at a premium (0.67%) meaning the ETF is trading at a higher price than the calculated NAV.